Showing results (11-20 of 155) with videos related to
Sort By:
Pageof 16
Leukemia & Lymphoma|November 4, 2009
Overcoming resistance in chronic myelogenous leukemiaSusannah Cooper, Francis J Giles, Michael R SavonaNature Reviews. Genetics|May 14, 2021
Germline risk of clonal haematopoiesisAlexander J Silver, Alexander G Bick, Michael R SavonaBritish Journal of Haematology|October 2, 2019
The evolving role of next generation sequencing in myelodysplastic syndromesTravis P Spaulding, Shannon S Stockton, Michael R SavonaOncotargets and Therapy|May 5, 2016
Therapeutic approaches in myelofibrosis and myelodysplastic/myeloproliferative overlap syndromesAndrew L Sochacki, Melissa A Fischer, Michael R SavonaCurrent Opinion in Hematology|January 31, 2016
Unfavorable-risk acute myeloid leukemia dissectedStephen A Strickland, Sanjay R Mohan, Michael R SavonaCurrent Hematologic Malignancy Reports|December 28, 2025
Impact of Germline DNA Repair Mutations on Clonal Hematopoiesis and Myeloid Neoplasm DevelopmentKateryna Fedorov, Leo Y Luo, Alexander G Bick, et al.Vaccine|January 4, 2020
Evidence of vaccinia dissemination despite lack of major reaction following smallpox vaccinationWilfred P Delacruz, Michael R Savona, Jennifer A Thornton, et al.American Journal of Hematology|March 5, 2009
The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemiaBradley A McGregor, Alexander W Brown, Michael B Osswald, et al.Infection Control and Hospital Epidemiology|October 24, 2007
Comparison of a semipermeable dressing bonded to an absorbent pad and a semipermeable dressing over a separate gauze pad for containment of vaccinia virus at the vaccination siteMichael R Savona, Wilfred P Dela Cruz, Jennifer A Thornton, et al.Blood Vessels, Thrombosis & Hemostasis|January 2, 2026
Limited availability of variant-specific germ line data creates challenges in the interpretation of myeloid NGS panelsAaron Jacob Winer, Emily F Mason, Alexander G Bick, et al.Pageof 16